Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer
Abstract Background Patients with high‐intermediate risk endometrial cancer (H‐IR EMCA) have an elevated risk of recurrence compared to low‐risk counterparts. Many H‐IR EMCA patients are treated with radiation or chemotherapy, but their overall survival is not significantly impacted by treatment. Th...
Guardado en:
Autores principales: | Rebecca C. Arend, Carly B. Scalise, Jhalak Dholakia, Maahum Z. Kamal, Haley B. Thigpen, David Crossman, Warner K. Huh, Charles A. Leath III |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/88d7d8534aaa441ab511558f98f4d091 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Sangam Jha, et al.
Publicado: (2021) -
An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
por: Chang Chih-Yen, et al.
Publicado: (2021) -
Can addition of frozen section analysis to preoperative endometrial biopsy and MRI improve identification of high-risk endometrial cancer patients?
por: Go Nakai, et al.
Publicado: (2021) -
Prognostic factors determining survival after extrapelvic recurrence in endometrioid type endometrial cancer
por: Fatih Kilic, et al.
Publicado: (2021) -
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?
por: Manolis Nikolopoulos, et al.
Publicado: (2021)